Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection

Biology Direct

Volumn 1, Issue , 2006, Pages

  Glazko, Galina V ^a   Babenko, Vladimir N ^b   Koonin, Eugene V ^b   Rogozin, Igor B ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE;

EID: 34248346357     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-1-4     Document Type: Review

References (29)

1. Hansen R Oren M p53; from inductive signal to cellular effect Curr Opin Genet Dev 1997 7 1 46-51 10.1016/S0959-437X(97)80108-6 9024633
2. Levine AJ p53, the cellular gatekeeper for growth and division Cell 1997 88 3 323-331 10.1016/S0092-8674(00)81871-1 9039259
3. Agarwal ML Taylor WR Chernov MV Chernova OB Stark GR The p53 network J Biol Chem 1998 273 1 1-4 10.1074/jbc.273.1.1 9417035
4. Guimaraes DP Hainaut P TP53: A key gene in human cancer Biochimie 2002 84 1 83-93 10.1016/S0300-9084(01)01356-6 11900880
5. Lane DP Benchimol S p53: Oncogene or anti-oncogene? Genes Dev 1990 4 1 1-8 2137806
6. Dittmer D Pati S Zambetti G Chu S Teresky AK Moore M Finlay C Levine AJ Gain of function mutations in p53 Nat Genet 1993 4 1 42-46 10.1038/ ng0593-42 8099841
7. Hsiao M Low J Dorn E Ku D Pattengale P Yeargin J Haas M Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness Am J Pathol 1994 145 3 702-714 8080050
8. Blagosklonny MV p53 from complexity to simplicity: Mutant p53 stabilization, gain-of-function, and dominant-negative effect Faseb J 2000 14 13 1901-1907 10.1096/fj.99-1078rev 11023974
9. Pugacheva EN Ivanov AV Kravchenko JE Kopnin BP Levine AJ Chumakov PM Novel gain of function activity of p53 mutants: Activation of the dUTPase gene expression leading to resistance to 5-fluorouracil Oncogene 2002 21 30 4595-4600 10.1038/sj.onc.1205704 12096336
10. Resnick MA Inga A Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity Proc Natl Acad Sci U S A 2003 100 17 9934-9939 187891 12909720 10.1073/ pnas.1633803100
11. Olive KP Tuveson DA Ruhe ZC Yin B Willis NA Bronson RT Crowley D Jacks T Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome Cell 2004 119 6 847-860 10.1016/j.cell.2004.11.004 15607980
12. Lang GA Iwakuma T Suh YA Liu G Rao VA Parant JM Valentin-Vega YA Terzian T Caldwell LC Strong LC El-Naggar AK Lozano G Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome Cell 2004 119 6 861-872 10.1016/j.cell.2004.11.006 15607981
13. Hurst LD The Ka/Ks ratio: Diagnosing the form of sequence evolution Trends Genet 2002 18 9 486 10.1016/S0168-9525(02)02722-1 12175810
14. Glazko GV Koonin EV Rogozin IB Mutation hotspots in the p53 gene in tumors of different origin: Correlation with evolutionary conservation and signs of positive selection Biochim Biophys Acta 2004 1679 2 95-106 15297143
15. Koonin EV Rogozin IB Glazko GV p53 gain-of-function: Tumor biology and bioinformatics come together Cell Cycle 2005 4 5 686-688 15846083
16. Gorlov IP Gorlova OY Amos CI Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53 Hum Mutat 2005 26 5 446-454 10.1002/ humu.20242 16173033
17. Walker DR Bond JP Tarone RE Harris CC Makalowski W Boguski MS Greenblatt MS Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features Oncogene 1999 18 1 211-218 10.1038/sj.onc.1202298 9926936
18. Denissenko MF Pao A Tang M Pfeifer GP Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 Science 1996 274 5286 430-432 10.1126/science.274.5286.430 8832894
19. Hainaut P Pfeifer GP Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis 2001 22 3 367-374 10.1093/carcin/22.3.367 11238174
20. Rodin SN Rodin AS On the origin of p53 G:C → T:A transversions in lung cancers Mutat Res 2002 508 1-2 1-19 12379456
21. Rogozin IB Pavlov YI Bebenek K Matsuda T Kunkel TA Somatic mutation hotspots correlate with DNA polymerase eta error spectrum Nat Immunol 2001 2 6 530-536 10.1038/88732 11376340
22. Pham P Bransteitter R Petruska J Goodman MF Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation Nature 2003 424 6944 103-107 10.1038/nature01760 12819663
23. Kotani A Okazaki IM Muramatsu M Kinoshita K Begum NA Nakajima T Saito H Honjo T A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression Proc Natl Acad Sci U S A 2005 102 12 4506-4511 555529 15767564 10.1073/pnas.0500830102
24. Cooper DN Youssoufian H The CpG dinucleotide and human genetic disease Hum Genet 1988 78 2 151-155 10.1007/BF00278187 3338800
25. Rogozin IB Pavlov YI Theoretical analysis of mutation hotspots and their DNA sequence context specificity Mutat Res 2003 544 1 65-85 10.1016/ S1383-5742(03)00032-2 12888108
26. Vogelstein B Kinzler KW Cancer genes and the pathways they control Nat Med 2004 10 8 789-799 10.1038/nm1087 15286780
27. Olivier M Eeles R Hollstein M Khan MA Harris CC Hainaut P The IARC TP53 database: New online mutation analysis and recommendations to users Hum Mutat 2002 19 6 607-614 10.1002/humu.10081 12007217
28. p16 mutation database [http://srs6.ebi.ac.uk/srs6bin/cgi-bin/ wgetz?-newId+-page+LibInfo+-lib+P16]
29. An Open Access On-Line Breast Cancer Mutation Data Base [(http://research.nhgri.nih.gov/bic/]